You just read:

Keryx Biopharmaceuticals, Inc. Announces Zerenex™ Phase 3 Data Presented at the 2013 World Congress of Nephrology

News provided by

Keryx Biopharmaceuticals, Inc.

03 Jun, 2013, 13:39 BST